Financhill
Back

Krystal Biotech Vs. Amicus Therapeutics Industry Stock Comparison

Sell
25

KRYS
Krystal Biotech

Last Price:
$165.06
Seasonality Move:
4.67%
Sell
44

FOLD
Amicus Therapeutics

Last Price:
$9.81
Seasonality Move:
5.47%
Sell
25
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $164.75. The Score for KRYS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.80. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $164.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.61 Sell
Relative Strength Index (14 RSI): 40.26 Sell
Chaikin Money Flow: 564694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.49 - 192.07) Sell
Bollinger Bands (100): (173.5 - 194.06) Sell

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 45.87 Sell
Chaikin Money Flow: 1508811 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.59 - 9.99) Buy
Bollinger Bands (100): (9.99 - 11.55) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.88 Sell
20-day SMA: 181.12 Sell
50-day SMA: 179.74 Sell
200-day SMA: 179.48 Sell
8-day EMA: 167.77 Sell
20-day EMA: 175.22 Sell
50-day EMA: 179.61 Sell
200-day EMA: 172.3 Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.82 Sell
20-day SMA: 9.84 Sell
50-day SMA: 10.45 Sell
200-day SMA: 10.64 Sell
8-day EMA: 9.79 Buy
20-day EMA: 9.9 Sell
50-day EMA: 10.25 Sell
200-day EMA: 10.81 Sell

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.65 per share, and an increase next year of $1.53 per share.

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):